Venlor
Intended to relieve major depressive symptoms to support central neurotransmitter balance and target chronic emotional distress.
- Category
- Antidepressants
- Active ingredient
- Venlafaxine
- Route
- Oral use
- Form
- Tablet
- Strengths
- 75mg
Prescription and consultation requirements for Venlor vary by destination and are determined by the fulfilment partner.
Venlor details
- Alternative names
- venlafaxine
- Therapeutic class
- Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
- Pharmacological class
- Antidepressant
- Known off-label uses
- panic disorder; hot flashes
- Contraindications
- concurrent MAO inhibitor use; severe uncontrolled hypertension
- Minor side effects
- nausea; somnolence; dry mouth
- Moderate side effects
- insomnia; sweating; sexual dysfunction
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Cipla Ltd
- Onset Time
- 1–4 weeks
- Duration
- 12–24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- MAO Inhibitors; Aspirin; NSAIDs
- Age restrictions
- Approved for adults over eighteen years.
Serious side effects
suicidal ideation, requires immediate medical attention; serotonin syndrome, requires immediate medical attention
Patient summary
intended to relieve major depressive symptoms to support central neurotransmitter balance and target chronic emotional distress.
Mechanism of action
Potently inhibits presynaptic reuptake transporters for serotonin and norepinephrine inside central brain networks.
Pregnancy and breastfeeding
TGA Category C: Fetal withdrawal risks in late pregnancy. Breastfeeding: Expelled in milk.